mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.02 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |